AG
Andrew Galler Morgan Stanley Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Immunocore
IMCR
$1.87B
| $37.20 | $35 |
6%
downside
| Equal-Weight | 6 months ago |
|
2
Amicus Therapeutics
FOLD
$2.46B
| $7.99 | $15 |
88%
upside
| Equal-Weight | 1 year ago |
|
|
SLN
3
Silence Therapeutics
SLN
$269M
| $5.69 | $18 |
216%
upside
| Equal-Weight | 2 years ago |
|
4
Arrowhead Research
ARWR
$4.02B
| $29.07 | $37 |
27%
upside
| Equal-Weight | 2 years ago |
|
5
Ionis Pharmaceuticals
IONS
$9.76B
| $61.23 | $56 |
9%
downside
| Overweight | 2 years ago |
|
6
Vir Biotechnology
VIR
$732M
| $5.27 | $18 |
242%
upside
| Underweight | 2 years ago |
|
7
PTC Therapeutics
PTCT
$4.55B
| $57.26 | $54 |
6%
downside
| Equal-Weight | 3 years ago |
|
8
Halozyme
HALO
$8.76B
| $74.93 | $50 |
33%
downside
| Overweight | 3 years ago |
|
9
ADC Therapeutics
ADCT
$398M
| $3.54 | $44 |
1,143%
upside
| Outperform | 3 years ago |
|
10
Moderna
MRNA
$9.78B
| $25.14 | $304 |
1,109%
upside
| Outperform | 3 years ago |
|